Aurobindo Pharma set to raise $300 million via QIP
The investment bankers have already launched soft marketing of the deal and are ready to launch the issue, depending on market conditions, sources said.
HSBC
-
Aster DM Healthcare promoters cut share pledge to 41% after refinancing debt
"The reduction in Aster's pledged shares is a significant testament to our financial strength as promoters, especially in light of the volatile global market conditions," Aster DM Healthcare Founder and Chairman Azad Moopen said.
-
Global execs commit to mental health
-
Piramal Pharma in talks for $225 million offshore loans
-
Coronavirus infections pass 100,000 as outbreak wreaks financial havoc
-
HSBC upgrades Torrent Pharma to 'buy' from 'hold'
-
Jubilant Life Sciences raises $300 million via bond issuance
-
Sun Pharma gets boost with US FDA approval for Gleevec
-
Dr Reddy’s sues AstraZeneca over purple colour of Nexium generic
-
Cipla appoints Naina Lal Kidwai as an independent director
Advertisement
More in HSBC
Advertisement
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
